Next Generation Sequencing: Emerging Clinical Applications and Global Markets

  • Published: July 2013
  • |
  • Report Code: BIO126A

REPORT HIGHLIGHTS

The next generation sequencing market reached $231.7 million in 2012. The market is expected to reach $510.7 million in 2013 and $7.6 billion in 2018 for a compound annual growth rate (CAGR) of 71.6%.

This report provides:

  • An overview of the global market for next-generation sequencing and its emerging clinical applications
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • Examination of the sequencing industry structure for the key market segments, as well as strategic alliances and acquisitions, as well as evaluations of sequencing patents
  • Discussion of the strategies of the main companies in the market
  • Comprehensive company profiles of major players in the field

SAMPLE FIGURE
CLINICAL NEXT GENERATION SEQUENCING MARKET BY DISEASE CLASS, 2012-2018
($ MILLIONS)
CLINICAL NEXT GENERATION SEQUENCING MARKET  BY DISEASE CLASS, 2012-2018
To Contact us, click here  help


Source: BCC Research

Download Report Overview

REPORT SCOPE

SCOPE AND FORMAT

The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents and companies.  The markets for NGS-based diagnostics are given for the years 2012, 2013 and 2018.

This report reviews the main sequencing technologies and explains why genetic variation is important in clinical testing.  It then discusses some of the top research initiatives that are contributing to clinical NGS applications.  Market driving forces are also discussed.

The report examines the markets by test complexity, indication and test purpose.  Test complexity refers to the multiplexing (e.g., the number of genes covered) and coverage (e.g., the extent to which the genome is covered) of the test.  Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics) will be in demand in the future.

The report provides market data and forecasts for NGS diagnostics by specific applications, including those for cancer, rare diseases, common diseases, and pre- and post-natal screening.

Specific geographic markets are discussed, including North America, Europe, China, Japan and the rest of the world.

Market data covers the years 2012, 2013 and 2018.

Industry sectors analyzed include NGS instruments, target enrichment, informatics, clinical laboratories and the prenatal screening industry.

More than 110 companies in the clinical NGS industry are profiled in this report.

BCC Research provides a summary of the main industry acquisitions and strategic alliances from 2011 through 2013, including key alliance trends.

ANALYST CREDENTIALS

John Bergin is the author of previous BCC biotechnology reports titled Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics; Global Biochip Markets: Microarrays and Lab-on-a-chip; RNA Interference in the Post-Genomics Era: Markets and Technologies; DNA Sequencing: Emerging Technologies and Applications; Biologic Imaging Reagents: Technologies and Global Markets; and Synthetic Biology: Emerging Global Markets.

Mr. Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with an emerging nanotechnology company.  Mr. Bergin holds a BS degree in Chemistry, an MS degree in Biotechnology and a Masters of Business Administration.


Download Report Overview

REPORT TOC

Pricing on the website is provided for single users and 2-5 users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at (+1)781-489-7301 or send an email to information@bccresearch.com
  Title/Chapter Name Pages Price
Next Generation Sequencing: Emerging Clinical Applications and Global Markets 195 $4655
Chapter- 1: INTRODUCTION - Complimentary 4 $0
  Show Details
Chapter- 2: EXECUTIVE SUMMARY 3 $250
  Show Details
Chapter- 3: OVERVIEW 8 $286
  Show Details
Chapter- 4: TECHNOLOGIES 29 $1038
  Show Details
Chapter- 5: CLINICAL NEXT GENERATION SEQUENCING APPLICATIONS 12 $430
  Show Details
Chapter- 6: CLINICAL NEXT GENERATION SEQUENCING INDUSTRY 28 $1003
  Show Details
Chapter- 7: NEXT GENERATION SEQUENCING DIAGNOSTICS MARKETS 30 $1074
  Show Details
Chapter- 8: PATENTS 5 $179
  Show Details
Chapter- 9: COMPANY PROFILES 76 $2721
  Show Details
 
  List of Tables
  List of Figures

Latest Version
BIO126B - June 2015

Select License type:

Original Price 6650.00
Offer Price $4655

buy now

Payment options: credit card, PayPal, wire transfer and check.

download report overview
Want to find out more
about this report?
request more info
Get Notified
on all the latest research reports
Subscribe